MOESM1 of Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes

作者：KAMEL MOHAMMEDI, Mark Woodward, Michel Marre, Stephen Colagiuri, Mark Cooper, Stephen Harrap, Giuseppe Mancia, Neil Poulter, B. Williams, Sophia Zoungas, John Chalmers · 发表于：Figshare · 年份：2017 · DOI：10.6084/m9.figshare.5254630 · 研究领域：Chronic Kidney Disease and Diabetes、Diabetes Treatment and Management、Adipokines, Inflammation, and Metabolic Diseases

Additional file 1: Table S1. Components of microvascular and macrovascular disease at baseline. Table S2. Distibution of patients, event rate (per 100 person years) and hazard ratios (HRs) for outcomes during follow-up, according to the history of microvascular (including chronic kidney disease) or macrovascular disease at baseline. Table S3. Distibution of patients, event rate (per 100 person years) and hazard ratios (HRs) for outcomes during follow-up, according to the history of microvascular (including peripheral neuropathy) or macrovascular disease at baseline. Table S4. Subdistribution hazard ratios for outcomes during follow-up according to the history of microvascular or macrovascular disease at baseline with correction for competing risk of non-renal and non-cardiovascular death.